Adult T-cell leukemia pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Adult T-cell leukemia}} {{CMG}} ==Overview== ==Pathophysiology== A TLL is usually a highly aggressive non-Hodgkin's lymphoma with no characteristic histologic...")
 
No edit summary
Line 6: Line 6:
==Pathophysiology==
==Pathophysiology==
A TLL is usually a highly aggressive [[non-Hodgkin's lymphoma]] with no characteristic histologic appearance except for a diffuse pattern and a mature T-cell phenotype. Circulating [[lymphocyte]]s with an irregular nuclear contour (leukemic cells) are frequently seen. Several lines of evidence suggest that HTLV-1 causes ATLL. This evidence includes the frequent isolation of HTLV-1 from patients with this disease and the detection of HTLV-1 proviral genome in ATLL leukemic cells. ATLL is frequently accompanied by visceral involvement, [[hypercalcemia]], lytic bone lesions, and [[skin lesion]]s.
A TLL is usually a highly aggressive [[non-Hodgkin's lymphoma]] with no characteristic histologic appearance except for a diffuse pattern and a mature T-cell phenotype. Circulating [[lymphocyte]]s with an irregular nuclear contour (leukemic cells) are frequently seen. Several lines of evidence suggest that HTLV-1 causes ATLL. This evidence includes the frequent isolation of HTLV-1 from patients with this disease and the detection of HTLV-1 proviral genome in ATLL leukemic cells. ATLL is frequently accompanied by visceral involvement, [[hypercalcemia]], lytic bone lesions, and [[skin lesion]]s.
===Transmission===
Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through [[blood transfusion]] or sharing of contaminated needles.
Infection with HTLV-1, like infection with other [[retroviruses]], probably occurs for life and can be inferred when antibody against HTLV-1 is detected in the [[blood plasma|serum]].


==References==
==References==

Revision as of 19:30, 18 September 2012

Adult T-cell leukemia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adult T-cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray Findings

Echocardiography and Ultrasound

CT scan

MRI Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adult T-cell leukemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adult T-cell leukemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adult T-cell leukemia pathophysiology

CDC on Adult T-cell leukemia pathophysiology

Adult T-cell leukemia pathophysiology in the news

Blogs on Adult T-cell leukemia pathophysiology

Directions to Hospitals Treating Adult T-cell leukemia

Risk calculators and risk factors for Adult T-cell leukemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

A TLL is usually a highly aggressive non-Hodgkin's lymphoma with no characteristic histologic appearance except for a diffuse pattern and a mature T-cell phenotype. Circulating lymphocytes with an irregular nuclear contour (leukemic cells) are frequently seen. Several lines of evidence suggest that HTLV-1 causes ATLL. This evidence includes the frequent isolation of HTLV-1 from patients with this disease and the detection of HTLV-1 proviral genome in ATLL leukemic cells. ATLL is frequently accompanied by visceral involvement, hypercalcemia, lytic bone lesions, and skin lesions.

Transmission

Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles.

Infection with HTLV-1, like infection with other retroviruses, probably occurs for life and can be inferred when antibody against HTLV-1 is detected in the serum.

References

Template:WH Template:WS